Arcus Biosciences, Inc. — Director's Dealing 2022

Mar 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2022-02-28

Reporting Person: Jaen Juan C. (Director, President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-28	Common Stock	G	350000	$0.00	Disposed	1222240	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	201157	Direct

Footnotes

F1: Gift to a family trust over which the reporting person has neither voting nor investment control.